147 related articles for article (PubMed ID: 16759884)
1. Changes in immunolocalisation of beta-dystroglycan and specific degradative enzymes in the osteoarthritic synovium.
Wimsey S; Lien CF; Sharma S; Brennan PA; Roach HI; Harper GD; Górecki DC
Osteoarthritis Cartilage; 2006 Nov; 14(11):1181-8. PubMed ID: 16759884
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis.
Tsushima H; Okazaki K; Hayashida M; Ushijima T; Iwamoto Y
Ann Rheum Dis; 2012 Jan; 71(1):99-107. PubMed ID: 21917825
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
4. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.
Prasadam I; Crawford R; Xiao Y
J Rheumatol; 2012 Mar; 39(3):621-34. PubMed ID: 22247346
[TBL] [Abstract][Full Text] [Related]
5. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
6. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.
Weng LH; Ko JY; Wang CJ; Sun YC; Wang FS
Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.
Ross TN; Kisiday JD; Hess T; McIlwraith CW
Osteoarthritis Cartilage; 2012 Dec; 20(12):1583-90. PubMed ID: 22917743
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK; Waters JG; Kevorkian L; Darrah C; Cooper A; Donell ST; Clark IM
Arthritis Res Ther; 2006; 8(4):R124. PubMed ID: 16859525
[TBL] [Abstract][Full Text] [Related]
9. Detection of ADAMTS-4 activity using a fluorogenic peptide-conjugated Au nanoparticle probe in human knee synovial fluid.
Peng S; Zheng Q; Zhang X; Dai L; Zhu J; Pi Y; Hu X; Cheng W; Zhou C; Sha Y; Ao Y
ACS Appl Mater Interfaces; 2013 Jul; 5(13):6089-96. PubMed ID: 23716507
[TBL] [Abstract][Full Text] [Related]
10. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions.
Roach HI; Yamada N; Cheung KS; Tilley S; Clarke NM; Oreffo RO; Kokubun S; Bronner F
Arthritis Rheum; 2005 Oct; 52(10):3110-24. PubMed ID: 16200590
[TBL] [Abstract][Full Text] [Related]
11. Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury.
Haslauer CM; Elsaid KA; Fleming BC; Proffen BL; Johnson VM; Murray MM
Osteoarthritis Cartilage; 2013 Dec; 21(12):1950-7. PubMed ID: 24036379
[TBL] [Abstract][Full Text] [Related]
12. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Hulejová H; Baresová V; Klézl Z; Polanská M; Adam M; Senolt L
Cytokine; 2007 Jun; 38(3):151-6. PubMed ID: 17689092
[TBL] [Abstract][Full Text] [Related]
13. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
14. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients.
Koskinen A; Vuolteenaho K; Nieminen R; Moilanen T; Moilanen E
Clin Exp Rheumatol; 2011; 29(1):57-64. PubMed ID: 21345293
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.
Kamm JL; Nixon AJ; Witte TH
Equine Vet J; 2010 Nov; 42(8):693-9. PubMed ID: 21039798
[TBL] [Abstract][Full Text] [Related]
16. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage.
da Silva MA; Yamada N; Clarke NM; Roach HI
J Orthop Res; 2009 May; 27(5):593-601. PubMed ID: 18985702
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
[TBL] [Abstract][Full Text] [Related]
18. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
Masuhara K; Nakai T; Yamaguchi K; Yamasaki S; Sasaguri Y
Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920
[TBL] [Abstract][Full Text] [Related]
19. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage.
Naito S; Shiomi T; Okada A; Kimura T; Chijiiwa M; Fujita Y; Yatabe T; Komiya K; Enomoto H; Fujikawa K; Okada Y
Pathol Int; 2007 Nov; 57(11):703-11. PubMed ID: 17922681
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.
Dickinson SC; Vankemmelbeke MN; Buttle DJ; Rosenberg K; Heinegård D; Hollander AP
Matrix Biol; 2003 May; 22(3):267-78. PubMed ID: 12853037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
